Skip to main content
SpringerLink
Log in

Linking myeloperoxidase with subclinical atherosclerosis in adults with metabolic syndrome

  • original article
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Summary

Backround

Myeloperoxidase (MPO) is a leukocyte-derived enzyme that has been associated with cardiovascular diseases in many studies. Together with hydrogen peroxide and a halogen, MPO forms a very strong antimicrobial system and there is evidence of links between MPO and inflammation in cardiovascular diseases. Brachial flow-mediated dilation (FMD) refers to a physiologic measure, and carotid intima-media thickness (IMT) is an anatomic structural measure of subclinical atherosclerosis. This research aimed to assess the correlation of MPO serum levels with subclinical atherosclerosis in patients with metabolic syndrome (MS) using the parameters FMD and IMT.

Methods

A total of 88 patients with metabolic syndrome defined according to the International Diabetes Criteria (IDF) criteria were recruited in the study. Doppler ultrasound was used to determine the left and right common carotid artery thickness (left and right CCA IMT) and FMD of brachial artery. The MPO concentrations were measured using the Immundiagnostik MPO ELISA kit.

Results

A significant inverse correlation between MPO and brachial FMD (r = −0.354, p < 0.001), a significant positive correlation between MPO and right CCA IMT (r = 0.327, p < 0.001), and a significant positive correlation between MPO and left CCA IMT (r = 0.301, p < 0.001) in patients with MS were obtained in this research study.

Conclusion

Serum MPO concentration is correlated with subclinical atherosclerosis in patients with MS. The MPO may be a potential therapeutic goal in patients with MS. This finding suggests that new biological markers for MS and subclinical atherosclerosis are helpful for understanding the mechanisms of the risk factors and their role as a considerable burden on the population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Fattahi MR, Niknam R, Safarpour A, Sepehrimanesh M, Lotfi M. The prevalence of metabolic syndrome in non-alcoholic fatty liver disease; a population-based study. Middle East J Dig Dis. 2016;8(2):131–7.

    Article  Google Scholar 

  2. Cuspidi C, Sala C, Provenzano F, Tadic M, Gherbesi E, Grassi G, et al. Metabolic syndrome and subclinical carotid damage: a meta-analysis from population-based studies. J Hypertens. 2018;36(1):23–30.

    Article  CAS  Google Scholar 

  3. Ronald JA. Imaging myeloperoxidase activity in cardiovascular disease. Curr Cardiovasc Imaging Rep. 2011;4:24–31.

    Article  Google Scholar 

  4. Rosenson RS, Brewer HB Jr, Ansell BJ, Barter P, Chapman MJ, Heinecke JW, et al. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol. 2016;13(1):48–60.

    Article  CAS  Google Scholar 

  5. Hafiane A, Genest J. High density lipoproteins: measurement techniques and potential biomarkers of cardiovascular risk. BBA Clin. 2015;3:175–88.

    Article  Google Scholar 

  6. Papageorgiou N, et al. Imaging subclinical atherosclerosis: where do we stand? Curr Cardiol Rev. 2017;13(1):47–55.

    Article  Google Scholar 

  7. Mancia G, De Backer G, Dominiczak A, et al. The task force for the management of arterial hypertension of the European sociey of hypertension (ESH) and of the European society of cardiology (ESC). 2007 guidelines for the management of arterial hypertension. Eur Heart J. 2007;28:1462–536.

    PubMed  Google Scholar 

  8. Koohi-Hosseinabadi O, Andisheh-Tadbir A, Bahadori P, Sepehrimanesh M, Mardani M, Tanideh N. Comparison of the therapeutic effects of the dietary and topical forms of zizyphus jujuba extract on oral mucositis induced by 5‑fluorouracil: a golden hamster model. J Clin Exp Dent. 2015;7(2):e304.

    Article  Google Scholar 

  9. Mardani M, Afra SM, Tanideh N, Andisheh Tadbir A, Modarresi F, Koohi-Hosseinabadi O, et al. Hydroalcoholic extract of carum carvi L. in oral mucositis: a clinical trial in male golden hamsters. Oral Dis. 2016;22(1):39–45.

    Article  CAS  Google Scholar 

  10. Tanideh N, Jamshidzadeh A, Sepehrimanesh M, Hosseinzadeh M, Koohi-Hosseinabadi O, Najibi A, et al. Healing acceleration of acetic acid-induced colitis by marigold (calendula officinalis) in male rats. Saudi J Gastroenterol. 2016;22(1):50.

    Article  Google Scholar 

  11. Cires-Drouet RS, et al. Imaging of high-risk carotid plaques: ultrasound. Semin Vasc Surg. 2017;30(1):44–53.

    Article  Google Scholar 

  12. Qu B, Qu T. Causes of changes in carotid intima-media thickness: a literature review. Cardiovasc Ultrasound. 2015;13:4.

    Article  Google Scholar 

  13. Daiber A, Steven S, Weber A, Shuvaev VV, et al. Targeting vascular (endothelial) dysfunction. Br J Pharmacol. 2017;174(12):1591–619.

    Article  CAS  Google Scholar 

  14. Velarde GP, Sherazi S, Kraemer DF, Bravo-Jaimes K, Butterfield R, Amico T, et al. Clinical and biochemical markers of cardiovascular structure and function in women with the metabolic syndrome. Am J Cardiol. 2015;116(11):1705–10.

    Article  CAS  Google Scholar 

  15. Vita JA, Brennan ML, Gokce N, Mann SA. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation. 2004;110(9):1134–9.

    Article  CAS  Google Scholar 

  16. van der Zwan LP, Teerlink T, Dekker JM, et al. Plasma myeloperoxidase is inversely associated with endothelium-dependent vasodilation in elderly subjects with abnormal glucose metabolism. Metabolism. 2010;59:1723–9.

    Article  Google Scholar 

  17. Sawicki M, Sypniewska G, Kozinski M, et al. Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes. Eur J Clin Invest. 2011;41:667–71.

    Article  CAS  Google Scholar 

  18. Meuwese MC, Stroes ES, Hazen SL, van Miert JN, Kuivenhoven JA, et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk prospective population study. J Am Coll Cardiol. 2007;50(2):159–65.

    Article  CAS  Google Scholar 

  19. Zaugg M, Lucchinetti E. Remote ischemic preconditioning in cardiac surgery—ineffective and risky? N Engl J Med. 2015;373:1470–2.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Internal Medicine Private Office, Timișoara, Romania

    Andreea Iana MD, PhD

  2. Physical Education and Sport Faculty, Department of Physical Therapy and Special Motility, West University of Timișoara, V. Parvan 5., 300233, Timișoara, Romania

    Elena Sirbu MD, PhD

Authors
  1. Andreea Iana MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elena Sirbu MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elena Sirbu MD, PhD.

Ethics declarations

Conflict of interest

A. Iana and E. Sirbu declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Iana, A., Sirbu, E. Linking myeloperoxidase with subclinical atherosclerosis in adults with metabolic syndrome. Wien Klin Wochenschr 132, 150–154 (2020). https://doi.org/10.1007/s00508-019-01602-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-019-01602-y

Keywords

Search

Navigation